Polymer excipients for biopharmaceutical formulations
US11945892B2 · kind B2 · utility
2Cited by
13References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 7, 2022 |
| Grant date | Apr 2, 2024 |
| Priority date | — |
| Expiry date | Oct 7, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/55555
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A polyacrylamide-based copolymer reduces or prevents aggregation of biologic molecules including proteins, peptides, and nucleic acids, and lipid-based vehicles such as liposomes, lipid nanoparticles, polymerosomes, and micelles, in aqueous formulations at hydrophobic interfaces, thereby increasing the thermal stability of the molecules in the formulation. Methods and compositions comprising the copolymer and a protein or the copolymer and insulin can be used for treating conditions including diabetes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.